Fabry disease: Effects of agalsidase-β shortage in Fabry disease

Nature Reviews Nephrology 11, 566 (2015). doi:10.1038/nrneph.2015.139 A shortage in agalsidase-β between 2009 and 2012 resulted in patients with Fabry disease either receiving reduced doses or switching to agalsidase-α. Lenders et al. found that patients who reduced doses or switched medications exhibited a decline in renal function compared to those
Source: Nature Reviews Nephrology - Category: Urology & Nephrology Tags: Research Highlight Source Type: research